Launch of Mebix tablet, a treatment for Alzheimer's type dementia
Memantine hydrochloride, the main ingredient in Mebix tablets, is the first and only drug to be recognized for its effectiveness in treating severe Alzheimer's type dementia. It not only improves dementia symptoms overall, but also improves daily life performance, memory, and cognitive function.
Mebix tablets block glutamate, a neurotransmitter that causes Alzheimer's type dementia, thereby protecting the brain so that the process of memory and learning can continue, preventing or slowing down the progression of the disease. It is a more fundamental treatment for Alzheimer's type dementia that has a neuroprotective effect by preventing the destruction of brain cells.
Mebix Tab.
●Ingredients/Content
Memantine HCl 10 mg
●Efficacy.Effectiveness
Treatment of moderate to severe Alzheimer's disease
●Usage. Dosage
1. Adults over 18 years of age: maximum daily dose of 20mg
Increase the dosage over the first 3 weeks: 5 mg per day (1/2 tablet in the morning) for the first week, 10 mg per day (1/2 tablet twice daily) for the second week, and 15 mg per day (1 tablet in the morning and 1/2 tablet in the evening) for the third week. From the 4th week, 20 mg per day (1 tablet twice per day) can be administered as a maintenance dose.
2. Elderly: For elderly patients over 65 years of age, administer 20 mg per day (10 mg twice a day).
●Insurance drug price: 1,262 won
●Insurance code: A17652171
●Packaging unit: 100 tablets